The pediatric brain tumors industry continues to expand rapidly as advancements in diagnostics and treatments improve survival rates and quality of life for affected children. This dynamic sector is driven by increasing awareness, technological innovations, and rising global investments targeting better therapeutic options. Market players actively adapt their portfolios to leverage new market...